AIM ImmunoTech issues Class I Common Stock Purchase Warrants in May 2026
AIM ImmunoTech Inc. filed an exhibit detailing the terms of Class I Common Stock Purchase Warrants, which are unregistered securities exercisable after stockholder approval. The warrants include standard anti-dilution provisions and define exercise mechanics tied to various trading market pricing methodologies.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day